A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis

Study on Investigational Medication for Children with Glucocorticoid-Induced Osteoporosis

Recruiting
5 years - 17 years
All
1 Location

Brief description of study.

We are doing this research study because we are trying to learn more about a drug called Denosumab in children with glucocorticoid-induced osteoporosis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Glucocorticoid-induced Osteoporosis
  • Age: 5 years - 17 years
  • Gender: All

Inclusion Criteria

Clinical diagnosis of GiOP

Other criteria exists-please contact study team

Updated on 19 Feb 2024. Study ID: 1809456517

This study investigates the effects of an investigational medication on children who have glucocorticoid-induced osteoporosis (GiOP). Osteoporosis is a condition where bones become weak and brittle, and glucocorticoid-induced means it is caused by certain medications known as glucocorticoids.

Participants in this study will receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine. The study will monitor the effects on bone health.

  • Who can participate: Children with a clinical diagnosis of glucocorticoid-induced osteoporosis are eligible to participate. For more detailed criteria, please contact the study team.
  • Study details: Participants will be assigned to receive either the investigational medication or a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here